Xinke Xu

MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression

Wei Chen, Xinke Xu, Junliang Li et al. · Oncotarget · 2017 · 149 citations · Full text

Medicine, Molecular Medicine, Pharmacology +17

IGF-1 induces hypoxia-inducible factor 1α-mediated GLUT3 expression through PI3K/Akt/mTOR dependent pathways in PC12 cells

Jian Yu, Junliang Li, Shanyi Zhang et al. · Brain Research · 2011 · 69 citations

Life Sciences, Cell Biology, Molecular Biology +12

Sevoflurane Induces Ferroptosis of Glioma Cells Through Activating the ATF4-CHAC1 Pathway

Yingyi Xu, Na Zhang, Cheng Chen et al. · Frontiers in Oncology · 2022 · 47 citations · Full text

Life Sciences, Cell Biology, Oncology +12

Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients

Dingyuan Luo, Wei Chen, Tian Yun et al. · OncoTargets and Therapy · 2017 · 37 citations · Full text

Medicine, Molecular Biology, Oncology +17

Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathway

Wei Chen, Kuan-Kei Kong, Xinke Xu et al. · International Journal of Oncology · 2017 · 35 citations · Full text

Medicine, Cancer Biology, Oncology +17